BBWI Bath & Body Works, Inc. - Fundamental Analysis
NEUTRAL
Sign in to save
Save this symbol to a watchlist or track a position.
BBWI Stock | Fundamental Analysis & Investment Insights
NYSE
Consumer Cyclical
Specialty Retail
Current Price
Live
$22.2
Analyst Target
$24.54
+10.5%
Upside
52W High
$41.87
52W Low
$14.28
At a glance
Key valuation, profitability, growth, and risk metrics.
Updated Jan 24, 2026
Market cap
$4.58B
P/E
6.87
ROE
N/A
Profit margin
9.5%
Debt/Equity
N/A
Dividend yield
3.6%
AI Analysis
Powered by advanced machine learning algorithms
Confidence Score
65%
Analysis Accuracy
BBWI's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability. The stock appears undervalued based on a low P/E of 6.87 and an intrinsic value estimate of $22.61, close to the current price of $22.20. However, declining revenue and earnings growth, along with negative Price/Book, raise sustainability concerns. While profitability margins and ROA are strong relative to peers, weak recent earnings surprises and bearish technical trends cap upside potential.
Key Strengths
Attractive valuation with P/E of 6.87 well below sector average of 55.88
High gross margin of 44.14% indicates strong pricing power and cost control
ROA of 15.29% significantly exceeds sector average of 6.28%
Dividend yield of 3.60% is high with a sustainable 24.77% payout ratio
Current price near 52-week low provides downside cushion
Key Risks
Piotroski F-Score of 4 suggests weak financial health and operational instability
Negative Price/Book ratio (-2.86) indicates shareholder equity deficit or accounting issues
Revenue and earnings declining YoY by -1.00% and -23.90% respectively
Poor recent earnings performance with 3 out of last 4 quarters missing estimates
Extremely low quick ratio of 0.26 signals potential liquidity risk
AI Fair Value Estimate
Based on comprehensive analysis
$22.61
+1.8% above current price
Performance Snowflake
Multi-dimensional analysis across 5 key categories
Overall
58
Moderate
85
40
55
42
70
AI Verdict
Mixed outlook with value offset by fundamental deterioration
Key drivers: Low valuation multiples, Declining earnings trend, Strong historical profitability, Poor short-term earnings execution, High dividend yield with low payout
Confidence
70%
Value
85/100
Ref P/E, PEG, Graham Number
Positives
- P/E of 6.87 is deeply discounted vs sector
- Price/Sales of 0.62 suggests undervaluation
- Intrinsic value ($22.61) nearly matches current price ($22.20)
Watchpoints
- Price/Book is negative (-2.86), invalidating traditional value metrics
- No Graham Number available due to negative book value
Future
40/100
Ref Growth rates
Positives
- Most recent Q/Q EPS growth of +16.7% shows potential rebound
Watchpoints
- Revenue growth YoY at -1.00%
- Earnings growth YoY down -23.90%
- Forward P/E of 8.55 implies only modest improvement
Past
55/100
Ref Historical trends
Positives
- Historically strong earnings surprises (e.g., +98.5%, +101.7%)
- Long-term profitability margins remain healthy
Watchpoints
- Recent quarters show deteriorating performance (3 of last 4 misses)
- 5-year price return down -30.8%, underperforming peers
Health
42/100
Ref Altman Z-Score, Piotroski F-Score
Positives
- Current ratio of 1.21 indicates basic short-term solvency
Watchpoints
- Piotroski F-Score of 4/9 indicates weak financial health
- Quick ratio of 0.26 is critically low
- Negative book value implies Altman Z-Score likely in distress zone
Dividend
70/100
Ref Yield, Payout
Positives
- Dividend yield of 3.60% is attractive
- Payout ratio of 24.77% is sustainable
Watchpoints
- Dividend Strength score is only 35/100, suggesting uncertainty in continuity
- No 5-year yield average available for trend analysis
Stock Price & Analyst Targets
Real-time price movements and analyst price targets
Current Price
$22.2
Analyst Target
$24.54
Upside/Downside
+10.5%
Multi-Horizon Performance vs Peers
Price momentum across 5Y → 1W horizons for BBWI and closest competitors.
Updated 2026-01-23
| Company | 5Y | 3Y | 1Y | 6M | 1M | 1W |
|---|---|---|---|---|---|---|
|
BBWI
Bath & Body Works, Inc.
Primary
|
-30.8% | -47.1% | -38.5% | -28.3% | +12.6% | -4.6% |
|
BGSI
Boyd Group Services Inc.
Peer
|
+3.0% | +3.0% | +3.0% | +3.0% | -0.1% | -1.3% |
|
ANF
Abercrombie & Fitch Co.
Peer
|
+294.4% | +242.8% | -22.4% | +4.3% | -24.0% | -7.5% |
|
ATMU
Atmus Filtration Technologies Inc.
Peer
|
+163.3% | +163.3% | +30.8% | +47.0% | +5.9% | -0.2% |
|
ABG
Asbury Automotive Group, Inc.
Peer
|
+51.8% | +25.9% | -8.4% | +0.2% | -1.2% | -3.9% |
Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.
Historical Performance Trends
Long-term financial metrics and growth patterns
Revenue & Net Income
Profit & Operating Margins
Return on Equity (ROE)
Quarterly Revenue Growth
Historical data shows last 12 quarters (3 years)
Valuation Metrics
Key valuation ratios and pricing indicators
P/E Ratio
6.87
Forward P/E
8.55
PEG Ratio
N/A
P/B Ratio
-2.86
P/S Ratio
0.62
EV/Revenue
1.26
EV/EBITDA
6.27
Market Cap
$4.58B
Profitability
Profit margins and return metrics
Profit Margin
9.5%
Operating Margin
10.1%
Gross Margin
44.14%
ROE
N/A
ROA
15.29%
Growth
Revenue and earnings growth rates
Revenue Growth
-1.0%
Earnings Growth
-23.9%
Q/Q Revenue Growth
N/A
Q/Q Earnings Growth
-27.4%
Financial Health
Balance sheet strength and liquidity metrics
Debt/Equity
N/A
Current Ratio
1.21
Good
Quick Ratio
0.26
Poor
Cash/Share
$1.15
Quarterly Earnings History
EPS performance vs analyst estimates
2026-02-26
$N/A
2025-11-20
$0.35
-11.9% surprise
2025-08-28
$0.3
-19.3% surprise
2025-05-29
$0.49
+4.0% surprise
Consumer Cyclical Sector Comparison
Comparing BBWI against 94 companies in the Consumer Cyclical sector
(5 bullish, 49 neutral, 40 bearish)
P/E Ratio
6.87
This Stock
vs
42.97
Sector Avg
-84.0%
(Discount)
Profit Margin
9.5%
This Stock
vs
0.78%
Sector Avg
+1118.9%
(Superior)
Revenue Growth
-1.0%
This Stock
vs
7.65%
Sector Avg
-113.1%
(Slower)
Current Ratio
1.21
This Stock
vs
1.88
Sector Avg
-35.6%
(Weaker)
Similar Companies
Peer comparison within the same industry
| Company | AI Rating | Market Cap | P/E | ROE | Profit Margin | Price | |
|---|---|---|---|---|---|---|---|
|
BBWI
Bath & Body Works, Inc.
|
NEUTRAL | $4.58B | 6.87 | -% | 9.5% | $22.2 | |
|
BGSI
Boyd Group Services Inc.
|
BEARISH | $4.62B | 222.77 | 1.9% | 0.5% | $162.62 | |
|
ANF
Abercrombie & Fitch Co.
|
NEUTRAL | $4.53B | 9.38 | 40.9% | 10.1% | $96.3 | |
|
ATMU
Atmus Filtration Technologies Inc.
|
NEUTRAL | $4.65B | 24.06 | 71.5% | 11.6% | $56.55 | |
|
ABG
Asbury Automotive Group, Inc.
|
NEUTRAL | $4.68B | 8.76 | 15.5% | 3.1% | $238.04 |
Recent Insider Trading
Insider buy and sell transactions from the last 6 months
| Date | Insider | Position | Transaction | Shares | Value |
|---|---|---|---|---|---|
| 2025-11-24 | NASH SARAH E | Director | Purchase | 10,000 | $155,800 |
| 2025-11-24 | SYMANCYK JAMES KEVIN | Director | Purchase | 22,500 | $350,550 |
| 2025-11-21 | VOSKUIL STEVEN E | Director | Purchase | 20,000 | $300,700 |
| 2025-11-21 | STEINOUR STEPHEN D | Director | Purchase | 6,700 | $99,528 |
| 2025-11-21 | HONDAL FRANCIS A | Director | Purchase | 3,343 | $50,128 |
| 2025-11-21 | BRADY LUCY | Director | Purchase | 3,469 | $49,962 |
Insider transactions can signal confidence or concerns about company prospects
Wall Street Analysts
Professional analyst ratings and price targets
Consensus
BUY
13 analysts
UBS
2026-01-08
Neutral
Neutral
Barclays
2026-01-06
Equal-Weight
Equal-Weight
Guggenheim
2025-12-10
Neutral
Citigroup
2025-11-21
Buy
Buy
Barclays
2025-11-21
Equal-Weight
Equal-Weight
UBS
2025-11-21
Neutral
Neutral
Wells Fargo
2025-11-21
Overweight
Overweight
B of A Securities
2025-11-21
Buy
Buy
Telsey Advisory Group
2025-11-21
Outperform
Market Perform
Morgan Stanley
2025-11-21
Overweight
Equal-Weight
Past News Coverage
Recent headlines mentioning BBWI from our newsroom.
Newest → oldest
No matching news yet.